Commonwealth Equity Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.75M | Sell |
|
|||||
|
2025
Q2 | $1.75M | Sell |
|
|||||
|
2025
Q1 | $2.04M | Buy |
|
|||||
|
2024
Q4 | $1.73M | Buy |
|
|||||
|
2024
Q3 | $1.55M | Buy |
|
|||||
|
2024
Q2 | $895K | Sell |
|
|||||
|
2024
Q1 | $897K | Buy |
|
|||||
|
2023
Q4 | $896K | Buy |
|
|||||
|
2023
Q3 | $695K | Sell |
|
|||||
|
2023
Q2 | $749K | Buy |
|
|||||
|
2023
Q1 | $735 | Sell |
|
|||||
|
2022
Q4 | $784K | Buy |
|
|||||
|
2022
Q3 | $684K | Buy |
|
|||||
|
2022
Q2 | $557K | Sell |
|
|||||
|
2022
Q1 | $610K | Buy |
|
|||||
|
2021
Q4 | $647K | Sell |
|
|||||
|
2021
Q3 | $712K | Sell |
|
|||||
|
2021
Q2 | $768K | Sell |
|
|||||
|
2021
Q1 | $764K | Sell |
|
|||||
|
2020
Q4 | $779K | Sell |
|
|||||
|
2020
Q3 | $639K | Buy |
|
|||||
|
2020
Q2 | $515K | Sell |
|
|||||
|
2020
Q1 | $484K | Buy |
|
|||||
|
2019
Q4 | $576K | Sell |
|
|||||
|
2019
Q3 | $816K | Sell |
|
|||||
|
2019
Q2 | $949K | Sell |
|
|||||
|
2019
Q1 | $993K | Buy |
|
|||||
|
2018
Q4 | $821K | Buy |
|
|||||
|
2018
Q3 | $1.03M | Buy |
|
|||||
|
2018
Q2 | $936K | Sell |
|
|||||
|
2018
Q1 | $859K | Sell |
|
|||||
|
2017
Q4 | $844K | Buy |
|
|||||
|
2017
Q3 | $882K | Buy |
|
|||||
|
2017
Q2 | $806K | Sell |
|
|||||
|
2017
Q1 | $919K | Sell |
|
|||||
|
2016
Q4 | $927K | Sell |
|
|||||
|
2016
Q3 | $1.23M | Sell |
|
|||||
|
2016
Q2 | $1.14M | Sell |
|
|||||
|
2016
Q1 | $1.27M | Sell |
|
|||||
|
2015
Q4 | $2.26M | Buy |
|
|||||
|
2015
Q3 | $1.99M | Buy |
|
|||||
|
2015
Q2 | $2.45M | Sell |
|
|||||
|
2015
Q1 | $2.38M | Buy |
|
|||||
|
2014
Q4 | $2.11M | Buy |
|
|||||
|
2014
Q3 | $1.64M | Buy |
|
|||||
|
2014
Q2 | $1.49M | Buy |
|
|||||
|
2014
Q1 | $1.2M | Buy |
|
|||||
|
2013
Q4 | $1.02M | Buy |
|
|||||
|
2013
Q3 | $790K | Sell |
|
|||||
|
2013
Q2 | $753K | Buy |
|